MetabolomicsWorkbenchapplication/xmlhttp://www.metabolomicsworkbench.org/rest/study/study_id/ST000317/mwtabprimaryOK200MetabolomicsMass SpectrometryESIBacteriahttp://www.metabolomicsworkbench.org/data/DRCCMetadata.php?Mode=Study&StudyID=ST000317Media type:EMedia type:ABacterial CellsUniversity of California, DavisReversed phase POSITIVE ION MODE. Reversed phase NEGATIVE ION MODE.MetabolomicsWorkbenchPC (p-32:0) or PC (o-32:1)TG (53:4)PI (38:4)PI (36:2)LPC (22:6)PE (p-36:4) or PE (o-36:5)TG (51:2)PE (38:4)TG (54:1)PC (38:4)SM (d42:1)PC (36:2)PE (36:2)TG (48:1)SM (d36:1)PE (p-38:4) or PE (o-38:5)TG (53:3)TG (50:4)PC (p-34:2) or PC (o-34:3)SM (d42:2)PC (38:5)PC (36:3)PC (p-38:5) or PC (o-38:6)PE (36:3)Acylcarnitine C16:0Ceramide (d40:1)PC (34:1)PC (p-40:6) or PC (o-40:7)TG (48:0)SM (d34:1)TG (56:1)TG (52:5)SM (d40:1)TG (50:3)PC (35:3)DG (36:2)PC (38:2)PC (33:1)PC (40:6)TG (42:1)SM (d34:2)TG (52:4)TG (58:2)Ceramide (d18:1/23:0)TG (50:2)TG (53:1)PC (p-40:5) or PC (o-40:6)SM (d40:2)TG (44:2)PC (38:3)PC (36:1)PE (p-36:2) or PE (o-36:3)DG (34:1)TG (49:3)Ceramide (d42:1)Ceramide (d40:1) _Ceramide (d40:1)TG (54:5)PC (o-32:0)TG (52:3)TG (50:1)TG (44:1)LPC (16:1)DG (34:2)TG (46:3)Ceramide (d36:1) _Ceramide (d36:1)PC (40:4)PC (32:2)TG (49:2)LPC (p-18:0) or LPC (o-18:1)SM (d32:1)TG (54:4)TG (56:6)TG (52:2)SM (d41:1)TG (50:0)LPC (16:0)TG (46:2)Acylcarnitine C18:1PC (35:2)Acylcarnitine C18:0PC (40:5)TG (49:1)LPC (o-16:0)TG (54:3)TG (52:1)TG (51:4)LPC (18:1)TG (46:1)PC (36:4)PC (34:2)PC (p-36:4) or PC (o-36:5)PC (32:0)PC (p-38:2) or PC (o-38:3)TG (48:3)TG (49:0)PI (38:3)PC (p-34:1) or PC (o-34:2)TG (54:2)PI (36:1)TG (52:0)TG (51:3)LPC (18:0)PC (37:2)TG (46:0)Ceramide (d41:1) _Ceramide (d41:1)PC (34:3)PE (36:1)PC (32:1)TG (48:2)SM (d33:1)Concept, development, Role Concept, postnatal development., Roles, growth pattern, non-developmental growth, Role Concepts, Role, Concepts, postnatal growth, growth and development, growthbackward, reversed., reversedfalseRole of medium in bacterial growthST000317